Meet Urological Surgeon Philip Pearson, M.D.
Meet Urological Surgeon Philip Pearson, M.D.

Philip G. Pearson, M.D.

  • Urologist
Make an Appointment

Philip G. Pearson, M.D.

Clinical Specialties
  • Urology and Urologic Oncology

Philip G. Pearson, M.D., is a board certified urologist who has practiced medicine in Pasadena, California, since 2007. Prior to practicing in Pasadena, Dr. Pearson was in private practice in urology in Seattle.

Dr. Pearson earned his medical doctorate from George Washington University School of Medicine in Washington, D.C. He began his higher education journey at the University of Virginia in Charlottesville where he earned a bachelor’s degree in psychology. After medical school, he completed internship and residency training in general surgery at the Swedish Medical Center in Seattle. Following this, he returned to his alma mater, the University of Virginia, to complete his urology residency training.

Dr. Pearson is a frequent presenter, researcher and lecturer. He has authored and co-authored several articles in urological literature.

Professional Experience

  • 2014-Present, Urologist, City of Hope, Pasadena, CA
  • 2007-2013, Foothill Urology Associates, Pasadena, CA
  • 2006, The Polyclinic, Seattle, WA
  • 2000-2006, Private Practice, Seattle, WA
  • 1999-2000, Pacific Urologic Consultants, Seattle, WA

Locations

Pasadena

630 S. Raymond Ave., Suite 220, Pasadena, CA, 91105

Get Directions

Phone :  626-218-9500

Arcadia

301 W. Huntington Drive, Suite 400, Arcadia, CA, 91007

Get Directions

Phone :  626-218-9840

Education

Degrees

  • 1994, M.D., George Washington University, Washington, D.C.
  • 1989, B.A., psychology, University of Virginia, Charlottesville, VA

Residency

  • 1996-1999, Resident in urology, University of Virgina, Charlottesville, VA
  • 1995-1996, Resident in surgery, Swedish Medical Center, Seattle, WA

Internship

  • 1995-1995, General surgery internship, Swedish Medical Center, Seattle, WA
  • 1987-1988, Laboratory intern, Laboratory of Neurochemistry, National Institute for Neurological and Communicative Disorders and Stroke, National Institutes of Health (LNC, NINCDS, NIH) Bethesda, MD

Publications

Abramson FP, Teffera Y, Kusmierz J, Steenwiyk RC, Pearson PG. Replacing 14C with stable isotopes in drug metabolism studies. Drug Metabolism and Disposition. 1996:24(7):697-701.
 
Pearson P, Lew S, Abramson F, Bosch J. Measurement of Kinectic Parameters for Urea in a Two-Compartment Model. Journal of the American Society of Nephrology. 1994:4(11):1869-73.
 
Duncan MW, Market SP, Weick BG, Pearson PG, Ziffer H, Kopin IJ. 2 amino-3 (methylamino)-propanioc acid (BMAA) bioavailability in the primate. Neurobiology of Aging. 1992:13:333-337.
 
Duncan MW, Villacreses NE, Pearson PG, Wyatt L, Rapoport SI, Kopin IJ, Markey SP, Smith QR. 2 amino-3-(methylamino)-propanioc acid (BMAA) pharmacokinetics and blood-barrier permeability in the rat. J. Pharmacl Exp Ther. 1991; 258(I):27-35.
 
Rowe RM, Link WT, Hazara AK, Pearson PG, Albers RW. Antibodies to synthetic peptides as probes of the struture of the alpha-subunit of the Na+,K+ATPase. Prog Clin Biol Res. 1998;268A:115-120.

Memberships

  • American Association of Clinical Urologists
  • American Board of Urology
  • American Urological Association, Western Section
  • Los Angeles Urological Society
Back To Top